[go: up one dir, main page]

Braunstein et al., 1981 - Google Patents

Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.

Braunstein et al., 1981

View PDF
Document ID
1654001115425896922
Author
Braunstein K
Noyes C
Griffith M
Lundblad R
Roberts H
et al.
Publication year
Publication venue
The Journal of Clinical Investigation

External Links

Snippet

Factor IXChapel Hill (Factor IXCH), an abnormal Factor IX molecule isolated from the plasma of a patient with mild hemophilia B, has previously been shown to exhibit delayed activation by Factor XIa and calcium. In this study, we have found that Factor IXCH is …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Similar Documents

Publication Publication Date Title
Bertina et al. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency
Bertina et al. Determination of plasma protein S-the protein cofactor of activated protein C
Bertina et al. Protein C deficiency in a Dutch family with thrombotic disease
Dahlbäck Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin
Braunstein et al. Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.
Schwarz et al. Plasma protein S deficiency in familial thrombotic disease
Stocker et al. Characterization of the protein C activator Protac® from the venom of the southern copperhead (Agkistrodon contortrix) snake
Kirby et al. Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme
Fair et al. Combined functional and immunochemical analysis of normal and abnormal human factor X
Sala et al. A functional assay of protein C in human plasma
Soria et al. A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis
Bertina Hereditary protein S deficiency
Comp et al. Determination of functional levels of protein C, an antithrombotic protein, using thrombin–thrombomodulin complex
Sas et al. Abnormal antithrombin III (antithrombin III ‘Budapest’) as a cause of a familial thrombophilia
Silverberg et al. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor
Griffith et al. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.
JP2008289498A (en) Purified multimerase
Bertina et al. Spectrophotometric assays of prothrombin in plasma of patients using oral anticoagulants
Malinconico et al. Hementin: anticoagulant protease from the salivary gland of the leech Haementeria ghilianii
ES2119165T5 (en) NEW ANTICOAGULATING COFACTOR ACTIVITY.
Abildgaard Inhibition of the thrombin-fibrinogen reaction by antithrombin III, studied by N-terminal analysis
Aznar et al. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level
Oehlin et al. Proteolytic formation and properties of a fragment of protein C containing the. gamma.-carboxyglutamic acid rich domain and the EGF-like region
JPH11507542A (en) Prothrombin derivative
Chung et al. Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.